Abstract:Microarrays are high throughput biological assays that allow the screening of thousands of genes for their expression. The main idea behind microarrays is to compute for each gene a unique signal that is directly proportional to the quantity of mRNA that was hybridized on the chip. A large number of steps and errors associated with each step make the generated expression signal noisy. As a result, microarray data need to be carefully preprocessed before their analysis can be assumed to lead to reliable and biologically relevant conclusions. This thesis focuses on developing methods for improving gene signal and further utilizing this improved signal for higher level analysis. To achieve this, first, approaches for designing microarray experiments using various optimality criteria, considering both biological and technical replicates, are described. A carefully designed experiment leads to signal with low noise, as the effect of unwanted variations is minimized and the precision of the estimates of the parameters of interest are maximized. Second, a system for improving the gene signal by using three scans at varying scanner sensitivities is developed. A novel Bayesian latent intensity model is then applied on these three sets of expression values, corresponding to the three scans, to estimate the suitably calibrated true signal of genes. Third, a novel image segmentation approach that segregates the fluorescent signal from the undesired noise is developed using an additional dye, SYBR green RNA II. This technique helped in identifying signal only with respect to the hybridized DNA, and signal corresponding to dust, scratch, spilling of dye, and other noises, are avoided. Fourth, an integrated statistical model is developed, where signal correction, systematic array effects, dye effects, and differential expression, are modelled jointly as opposed to a sequential application of several methods of analysis. The methods described in here have been tested only for cDNA microarrays, but can also, with some modifications, be applied to other high-throughput technologies.

Research progress of endothelial-to-mesenchymal transition

[Research progress on the role of epithelial-mesenchymal transition in pathogenesis of endometriosis].

EndMT: A promising and controversial field

Acetate Controls Endothelial-to-mesenchymal Transition

Endothelial-to-Mesenchymal Transition in Cardiovascular Pathophysiology

In Brief: Endothelial-To-Mesenchymal Transition

The Role of Endothelial-to-Mesenchymal Transition in Cardiovascular Disease

TGF-β-Induced Endothelial to Mesenchymal Transition in Disease and Tissue Engineering

Endothelial-to-mesenchymal transition: Pathogenesis and therapeutic targets for chronic pulmonary and vascular diseases

Endothelial to Mesenchymal Transition in Pulmonary Vascular Diseases

Endothelial to mesenchymal transition in cardiovascular diseases: Developmental signalling pathways gone awry.

Advances in regulating endothelial-mesenchymal transformation through exosomes

The Therapeutic Potential of Targeting the Endothelial-to-mesenchymal Transition

[Endothelial-mesenchymal transition, ventricular remodeling after myocardial infarction, and research progress of Chinese medicine intervention]

The research progress of epithelial-mesenchymal transition in tumor invasion and metastasis

TGF-β-mediated Endothelial to Mesenchymal Transition (EndMT) and the Functional Assessment of EndMT Effectors using CRISPR/Cas9 Gene Editing.

Abstract 15392: Exosomal Microrna 486-5P Mediates Cardiac Angiogenesis Post Myocardial Infarction by Targeting MMP19 in Fibroblasts

TGF--mediated Endothelial to Mesenchymal Transition (EndMT) and the Functional Assessment of EndMT Effectors using CRISPR/Cas9 Gene Editing

Endothelial-to-mesenchymal transition in tumour progression and its potential roles in tumour therapy

Methods to improve gene signal: Application to cDNA microarrays

Experimental Models to Study Endothelial to Mesenchymal Transition in Myocardial Fibrosis and Cardiovascular Diseases